Dodge & Cox Haleon PLC Transaction History

Dodge & Cox

$160 Billion
Q4 2024

A detailed history of Dodge & Cox transactions in Haleon PLC stock. As of the latest transaction made, Dodge & Cox holds 178,744,926 shares of HLN stock, worth $1.77 Billion. This represents 1.07% of its overall portfolio holdings.

Number of Shares

178,744,926

Previous 179,172,383 0.24%

Holding current value

$1.77 Billion

Previous $1.9 Billion 9.86%

% of portfolio

1.07%

Previous 1.15%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$9.23 - $10.71 $3.95 Million - $4.58 Million	-427,457 Reduced 0.24%	178,744,926 $1.71 Billion
Q3 2024 Nov 13, 2024	SELL	$8.32 - $10.7 $8.31 Million - $10.7 Million	-998,252 Reduced 0.55%	179,172,383 $1.9 Billion
Q2 2024 Aug 13, 2024	BUY	$8.01 - $8.64 $25.8 Million - $27.8 Million	3,217,384 Added 1.82%	180,170,635 $1.49 Billion
Q1 2024 May 14, 2024	BUY	$8.02 - $8.67 $532 Million - $575 Million	66,290,153 Added 59.9%	176,953,251 $1.5 Billion
Q4 2023 Feb 15, 2024	BUY	$7.78 - $8.62 $9.84 Million - $10.9 Million	1,265,239 Added 1.16%	110,663,098 $911 Million
Q3 2023 Nov 14, 2023	SELL	$7.85 - $8.94 $9.65 Million - $11 Million	-1,229,035 Reduced 1.11%	109,397,859 $911 Million
Q2 2023 Aug 14, 2023	SELL	$8.04 - $9.0 $11.5 Million - $12.9 Million	-1,428,711 Reduced 1.28%	110,626,894 $927 Million
Q1 2023 May 12, 2023	BUY	$7.57 - $8.37 $118 Million - $130 Million	15,545,632 Added 16.11%	112,055,605 $912 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.06 $138 Million - $187 Million	23,144,401 Added 31.55%	96,509,973 $772 Million
Q3 2022 Nov 10, 2022	BUY	$5.63 - $7.5 $413 Million - $550 Million	73,365,572 New	73,365,572 $447 Million

Others Institutions Holding HLN

# of Institutions

659

Shares Held

432M

Call Options Held

269K

Put Options Held

40.6K

View Full List

About Haleon plc

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $45.7B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

More about HLN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Dodge & Cox with notifications on news.

Account